Bharat Biotech has commenced direct supply of its COVID-19 vaccine \u2018Covaxin\u2019 to 14 States, including Delhi and Maharashtra, with effect from May 1, according to the company\u2019s Joint Managing Director Suchitra Ella.<\/p>\n
The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the States based on the allocations received by the Central government.<\/p>\n
\u201cBharat Biotech confirms direct supplies of COVAXIN to the following State govt\u2019s since 1\/5\/21, based on the allocations received by GoI. Requests have been received from other States, & will be processed for distribution based on availability of stocks 24×7,\u201d Ms. Ella tweeted.<\/p>\n
The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.<\/p>\n
On April 29, Bharat Biotech announced a cut in the price of \u2018Covaxin\u2019 for States to \u20b9400 per dose from the earlier \u20b9600 per dose.<\/p>\n
This followed widespread criticism of its pricing policy as it sold Covaxin to the Central government at \u20b9150 per dose.<\/p>\n
India has announced expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.<\/p>\n